Indeed, inhibition of the TLR4 signaling pathway by TIPE2 inhibits the TLR4-mediated CRC development by regulating the TLR4 inflammatory effect and inhibiting further amplification of the cascade reactions [44]. Here, TIPE2 is linked to colorectal carcinoma.